[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344863-105":59,"doc-detail-344863-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","when-estrogen-signaling-refuses-to-die-receptor-rewiring-compartmentalization-and-endocrine-plasticity-in-gynecological-cancers","When Estrogen Signaling Refuses to Die - Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers","","Estrogen signaling has a crucial but highly context-dependent role in gynecological cancers, often producing contradictory tumor-promoting or tumor-suppressive outcomes. This review consolidates evidence across cervical, ovarian, and endometrial cancers, emphasizing receptor subtype balance, isoform diversity, cellular localization, and epigenetic control. Estrogen receptor activity is framed as a dynamic, plastic signaling network, including persistence through alternative ERα forms and ERβ/GPER1 signaling in cervical tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/when-estrogen-signaling-refuses-to-die-receptor-rewiring-compartmentalization-and-endocrine-plasticity-in-gynecological-cancers/344863/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/when-estrogen-signaling-refuses-to-die-receptor-rewiring-compartmentalization-and-endocrine-plasticity-in-gynecological-cancers/344863.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is estrogen signaling described as context-dependent in gynecological cancers?","Question",{"text":112,"@type":113},"Its effects vary by tumor type, disease stage, cellular environment, and receptor subtype/isoform patterns, leading to tumor-promoting or tumor-suppressive outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which main estrogen receptor mechanisms are emphasized across the cancers reviewed?",{"text":117,"@type":113},"Receptor subtype balance, isoform diversity, cellular/subcellular localization, and epigenetic regulation are highlighted as drivers of dynamic signaling behavior.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review characterize estrogen receptor expression in cancer?",{"text":121,"@type":113},"It is presented not as a static marker, but as a dynamic and plastic signaling network that can rewire through non-classical pathways and regulatory layers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344863,1790169721,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nWhen Estrogen Signaling Refuses to Die: Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers  \nJimena P. Cabilla  and María Teresa L. Pino *  \nAcademic Editor: Antonio d’Amati  \nReceived: 11 January 2026  \nRevised: 6 February 2026  \nAccepted: 8 February 2026  \nPublished: 17 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nCentro de Altos Estudios en Ciencias Humanas y de la Salud, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Abierta Interamericana, Buenos Aires C1270AAH, Argentina; [jimena.cabilla@uai.edu.ar](jimena.cabilla@uai.edu.ar)  \n* [Correspondence: maria.pino@uai.edu.ar](Correspondence: maria.pino@uai.edu.ar); Tel.: +54-11-4301-5240  \nAbstract  \nAlthough estrogen signaling plays an important role in gynecological cancers, its function is highly context-dependent and often contradictory. Estrogen receptors have been associated with both tumor-promoting and tumor-suppressive effects depending on the tumor type, disease stage, and cellular environment. This review summarizes the current evidence on estrogen receptor signaling in cervical, ovarian, and endometrial cancers, focusing on receptor subtype balance, isoform diversity, cellular and subcellular localization, and epigenetic regulation. Rather than a static marker, estrogen receptor expression is revealed as a dynamic and plastic signaling network. In cervical cancer, estrogen signaling persists despite the loss of epithelial estrogen receptor α (ERα) through stromal signaling, alternative ERα isoforms, ERβ, and non-classical receptors such as G protein-coupled estrogen receptor 1 (GPER1) . In ovarian cancer, epigenetic silencing of ERβ and ERα predominance drivesoncogenic signaling while also creating specific biological vulnerabilities. In endometrial cancer, estrogen signaling shifts from hormone-dependent initiation to progressive oncogenic autonomy through receptor rewiring and non-genomic pathways. By integrating these mechanisms, this review highlights estrogen receptor plasticity as a unifying concept across gynecological malignancies and outlines key knowledge gaps that are relevant for future endocrine strategies.  \nKeywords: cervical cancer; ovarian cancer; endometrial cancer; estrogen receptor alpha; estrogen receptor beta; GPER1; cell signaling  \n1. Introduction  \nEstrogen signaling plays a central role in the physiology of the female reproductive system and in the development and progression of gynecological malignancies [1,2] . Although estrogen receptors have been studied extensively for decades, their functions in cancer remain paradoxical and highly context-dependent [3,4] . Depending on receptor subtype, isoform expression, subcellular localization, cellular composition, and microenvironmental cues, estrogen signaling may drive proliferation, differentiation, invasion, or therapeutic resistance [5–8] .  \nThese divergent outcomes cannot be explained by receptor expression alone. Accumulating evidence indicates that estrogen responses arise from a dynamic and adaptable signaling network involving receptor crosstalk, non-genomic pathways, epigenetic mechanisms, and non-coding RNA regulation [2,9,10] . This complexity has generated apparently  \nconflicting observations across tumor types, disease stages, and experimental models, underscoring the need for an integrative conceptual framework [8,11,12] .  \nIn this context, the present review synthesizes the current knowledge on estrogen receptor biology and signaling in gynecological malignancies. The structural and functional features of estrogen receptors and their major signaling modalities are first addressed, followed by an integrated overview of estrogen receptor expression and dynamics in normal gynecological tissues across the menstrual cycle a","cbCaiexiJSfYidWy","https://ap.wps.com/l/cbCaiexiJSfYidWy","pdf",2072901,41,"English","# Abstract\n# 1. Introduction\n# 2. Estrogen\n## Estrogen roles and sources","[{\"question\":\"Why is estrogen signaling described as context-dependent in gynecological cancers?\",\"answer\":\"Its effects vary by tumor type, disease stage, cellular environment, and receptor subtype/isoform patterns, leading to tumor-promoting or tumor-suppressive outcomes.\"},{\"question\":\"Which main estrogen receptor mechanisms are emphasized across the cancers reviewed?\",\"answer\":\"Receptor subtype balance, isoform diversity, cellular/subcellular localization, and epigenetic regulation are highlighted as drivers of dynamic signaling behavior.\"},{\"question\":\"How does the review characterize estrogen receptor expression in cancer?\",\"answer\":\"It is presented not as a static marker, but as a dynamic and plastic signaling network that can rewire through non-classical pathways and regulatory layers.\"}]","When Estrogen Signaling Refuses to Die - Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers | PDF",1790055480,103,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae6ee24cda71333d9584e6fbf5b31c5c.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4703a0dedda2209d491eb2442c7a1d2.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d664667bda388a265b41786d77c8b41e.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/689464f0a4578e17214b5170a85a8f3c.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eebcdcc49d0f0ca082a60cf613248a78.webp",979,1384]